Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARGRAMOSTIM vs SAXAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARGRAMOSTIM vs SAXAGLIPTIN: Safety Overview

Metric SARGRAMOSTIM SAXAGLIPTIN
Total FAERS Reports 593 2,468
Deaths Reported 85 263
Death Rate 14.3% 10.7%
Hospitalizations 138 838
Average Patient Age 34.4 yrs 65.5 yrs
% Female Patients 43.5% 47.8%
FDA Approval Date N/A Jul 31, 2009
Manufacturer Partner Therapeutics, Inc. Glenmark Pharmaceuticals Inc., USA
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued